Pearls and pitfalls in lung cancer staging.


Journal

BJR open
ISSN: 2513-9878
Titre abrégé: BJR Open
Pays: England
ID NLM: 101749810

Informations de publication

Date de publication:
2020
Historique:
received: 19 05 2020
revised: 15 06 2020
accepted: 16 06 2020
entrez: 12 11 2020
pubmed: 13 11 2020
medline: 13 11 2020
Statut: epublish

Résumé

Lung cancer is the third most common cancer in the UK and is the leading cause of death. Radiology plays a central role in the diagnostic work-up of patients with suspected and known lung cancer. Tumour assessment includes both local staging, as well as distant staging. Local staging objectives include the assessment of technical resectability with regard to the evaluation of tumour size and invasion of surrounding structures. Distant staging objectives aim to identify distant metastasis in lymphatic and extra lymphatic tissues. CT, positron emission tomography/CT, MRI, and ultrasound are routinely used imaging techniques for staging in patients with lung cancer. In this review, we will consider the pitfalls of these examinations that radiologists potentially face during the work-up of patients with lung cancer.

Identifiants

pubmed: 33178978
doi: 10.1259/bjro.20200019
pmc: PMC7594898
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

20200019

Informations de copyright

© 2020 The Authors. Published by the British Institute of Radiology.

Références

Nucl Med Commun. 2017 Dec;38(12):1117-1124
pubmed: 28953208
Cancers (Basel). 2014 Sep 29;6(4):1821-89
pubmed: 25268160
Med Oncol. 2003;20(1):25-8
pubmed: 12665681
Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21
pubmed: 28881918
Eur J Radiol. 2012 May;81(5):1007-15
pubmed: 21354739
Ther Adv Med Oncol. 2014 May;6(3):101-14
pubmed: 24790650
Radiology. 2017 Nov;285(2):584-600
pubmed: 28650738
Strahlenther Onkol. 2017 May;193(5):392-401
pubmed: 28246699
Tumori. 2006 Jul-Aug;92(4):327-33
pubmed: 17036525
Radiol Clin North Am. 2018 May;56(3):419-435
pubmed: 29622077
Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):29-35
pubmed: 16193311
Med Clin North Am. 2011 Nov;95(6):1041-54
pubmed: 22032426
Eur J Radiol. 2007 Dec;64(3):401-5
pubmed: 17870274
Lung Cancer. 2010 Aug;69(2):203-8
pubmed: 19945190
J Nucl Med. 2001 Dec;42(12):1795-9
pubmed: 11752075
Thorax. 2015 Feb;70(2):192-3
pubmed: 25077699
J Thorac Oncol. 2012 Oct;7(10):1485-9
pubmed: 22982649
N Engl J Med. 2017 Aug 31;377(9):849-861
pubmed: 28854088
Br J Radiol. 2018 May;91(1085):20170782
pubmed: 29393668
Memo. 2018;11(2):138-143
pubmed: 29983829
AJR Am J Roentgenol. 1999 Jul;173(1):15-22
pubmed: 10397092
J Thorac Oncol. 2009 May;4(5):568-77
pubmed: 19357537
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27
pubmed: 27664245
J Thorac Oncol. 2016 Aug;11(8):1204-1223
pubmed: 27107787
Cochrane Database Syst Rev. 2014 Nov 13;(11):CD009519
pubmed: 25393718
Ann Thorac Surg. 1996 Jul;62(1):246-50
pubmed: 8678651
Chest. 2013 May;143(5 Suppl):e211S-e250S
pubmed: 23649440
Eur Rev Med Pharmacol Sci. 2012 Dec;16(14):1908-14
pubmed: 23242715
J Thorac Oncol. 2016 May;11(5):639-650
pubmed: 26940528
J Thorac Oncol. 2015 Nov;10(11):1515-22
pubmed: 26536193
Eur Radiol. 2013 Aug;23(8):2187-96
pubmed: 23519439
N Engl J Med. 1995 Dec 28;333(26):1757-63
pubmed: 7491141
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv192-iv237
pubmed: 30285222
Chest. 2017 Apr;151(4):776-785
pubmed: 27713056
Med Oncol. 2009;26(2):147-50
pubmed: 18821066
J Thorac Oncol. 2016 Jan;11(1):39-51
pubmed: 26762738
BMJ. 2019 Mar 28;364:l1049
pubmed: 30923038
J Magn Reson Imaging. 2005 Aug;22(2):234-41
pubmed: 16028243
AJR Am J Roentgenol. 2017 Jun;208(6):1206-1217
pubmed: 28225653
Eur Radiol. 2019 Oct;29(10):5247-5252
pubmed: 30915563
J Thorac Oncol. 2015 Jul;10(7):990-1003
pubmed: 26134221

Auteurs

Ankush Jajodia (A)

Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.

Helmut Prosch (H)

Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Classifications MeSH